NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 49,922 US Dollar | 12 | 3 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 119.537.169 | 13,81 | 8,28 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name NewAmsterdam Pharma Company N.V. Ordinary Shares
Mitarbeiter 100
Handelsplatz NASDAQ
Ticker Symbol NAMS
IPO Datum 2022-11-23
Adresse Gooimeer 2-35, Naarden, Netherlands, 1411 DC
Webseite https://www.newamsterdampharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Michael Harvey Davidson FACC, Facp., M.D. | CEO, President & Executive Director |
| 2 | Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D. | Founder, Chief Scientific Officer, Member of Executive Board & Director |
| 3 | Mr. Mayur Amrat Somaiya | Chief Financial Officer |
| 4 | Mr. Robert W. Gunning CPA, CGMA | Principal Accounting Officer, VP & Controller |
| 5 | Mr. Matthew Philippe | Executive VP & Head of Investor Relations |
| 6 | Mr. Michael F. Marino Esq. | Chief Legal Officer & Corporate Secretary |
| 7 | Mr. Chris Deluzio | Executive Vice President of Sales Enterprise Operations |
| 8 | Ms. Maryellen McQuade | Chief People Officer |
| 9 | Ms. Juliette Audet M.B.A., M.Sc. | Chief Strategy & Business Officer |
| 10 | Dr. Marc Ditmarsch M.D. | Chief Development Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 15,13% | 0,38 Mrd. USD |
| 2 | Capital World Investors | 10,23% | 0,25 Mrd. USD |
| 3 | FMR Inc | 8,65% | 0,22 Mrd. USD |
| 4 | RA Capital Management, LLC | 7,99% | 0,20 Mrd. USD |
| 5 | FCPM III SERVICES BV | 7,10% | 0,18 Mrd. USD |
| 6 | Deerfield Management Co | 3,57% | 0,09 Mrd. USD |
| 7 | Viking Global Investors LP | 3,52% | 0,09 Mrd. USD |
| 8 | Bain Capital Life Sciences Investors, LLC | 3,18% | 0,08 Mrd. USD |
| 9 | Maverick Capital Ltd | 2,73% | 0,07 Mrd. USD |
| 10 | Duquesne Family Office LLC | 2,57% | 0,06 Mrd. USD |
| 11 | Jupiter Topco LLC | 2,12% | 0,05 Mrd. USD |
| 12 | HHG PLC | 1,89% | 0,05 Mrd. USD |
| 13 | Medicxi Ventures Management (Jersey) Ltd | 1,85% | 0,05 Mrd. USD |
| 14 | Jennison Associates LLC | 1,76% | 0,04 Mrd. USD |
| 15 | Orbis Allan Gray Ltd | 1,46% | 0,04 Mrd. USD |
| 16 | Polar Capital Holdings PLC | 1,44% | 0,04 Mrd. USD |
| 17 | Capital Research & Mgmt Co - Division 3 | 1,44% | 0,04 Mrd. USD |
| 18 | The Goldman Sachs Group Inc | 1,29% | 0,03 Mrd. USD |
| 19 | Westfield Capital Management Company, L.P. | 1,29% | 0,03 Mrd. USD |
| 20 | Castle Hook Partners LP | 1,15% | 0,03 Mrd. USD |